For: | Li YR, Hu TH, Chen WC, Hsu PI, Chen HC. Screening and prevention of hepatitis C virus reactivation during chemotherapy. World J Gastroenterol 2021; 27(31): 5181-5188 [PMID: 34497443 DOI: 10.3748/wjg.v27.i31.5181] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i31/5181.htm |
Number | Citing Articles |
1 |
Jinyong Wang, Di Dai, Ying Wen. Repeated Hepatitis C Virus Recurrence in a Patient With a Prognosis of Ultimate Spontaneous Clearance: Relapse or Reinfection?. American Journal of Therapeutics 2023; 30(5): e470 doi: 10.1097/MJT.0000000000001602
|
2 |
Anna Maria Spera. Safety of direct acting antiviral treatment for hepatitis C in oncologic setting: A clinical experience and a literature review. World Journal of Hepatology 2022; 14(3): 525-534 doi: 10.4254/wjh.v14.i3.525
|
3 |
Yu-Ming Wang, Sheng-Dean Luo, Ching-Nung Wu, Shao-Chun Wu, Wei-Chih Chen, Yao-Hsu Yang, Tai-Jan Chiu. The Impact of Clinical Prognosis of Viral Hepatitis in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy. Biomedicines 2023; 11(11): 2946 doi: 10.3390/biomedicines11112946
|